期刊文献+

U0126对急性白血病细胞HL-60增殖与凋亡的影响 被引量:1

Effect of U0126 on Proliferation and Apoptosis in Acute Leukemia Cell HL-60
下载PDF
导出
摘要 目的:探讨U0126对急性白血病细胞HL-60增殖与凋亡的影响。方法:用不同浓度(0、5、10、20μmol/L)的U0126处理HL-60细胞24、48、72 h,MTT法检测细胞活力,Hoechst染色检测细胞形态,EdU染色检测细胞增殖,流式细胞术检测细胞周期,Western blot检测细胞中增殖细胞核抗原(PCNA)、生存素(Survivin)、p21和p27表达及细胞外调节蛋白激酶(ERK1/2)磷酸化水平。结果:5、10、20μmol/L的U0126处理HL-60细胞24、48、72 h,能显著提高细胞增殖抑制率(P<0.01),具有时间与剂量依赖性(r=0.421、0.478)。与0μmol/L比较,5、10、20μmol/L的U0126能使细胞核发白,致密浓染,细胞增殖率降低(P<0.01),细胞周期阻滞在G1期(P<0.01),PCNA、Survivin及p-ERK1/2表达均下调(P<0.01),p21与p27表达均上调(P<0.01)。结论:U0126能显著抑制白血病细胞HL-60增殖,诱导细胞凋亡。 Objective:To explore the effect of U0126 on proliferation and apoptosis in acute leukemia cell HL-60.Method:U0126 cell was cultured with 0,5,10,20μmol/L dose of U0126 for 24,48,72 h.Cell viability was measured by MTT assay.Cell morphology was detected by Hoechst stainning.Cell proliferation was detected by EdU staining.Cell cycle was measured by flow cytometry.The expression of Proliferating Cell Nuclear Antigen(PCNA),Survivin,p21,p27 and the level of extracellular regulated protein kinases(ERK1/2)phosphorylation were measured by Western blot.Result:HL-60 cell viability was reduced for treatment with 5,10,20μmol/L dose of U0126 for 24,48,72 h(P<0.01),time-and dose-dependent manner(r=0.421,0.478).5,10,20μmol/L dose of U0126 reduced cell proliferation rate(P<0.01),made cell nucleus dense and thick,made cell cycle arrested in the G1 phase(P<0.01),down-regulated the expression of PCNA,Survivin and p-ERK1/2(P<0.01),up-regulated the expression of p21 and p27(P<0.01).Conclusion:U0126 can significantly inhibit the proliferation of HL-60 cells and induce apoptosis.
作者 郭金刚 类承斌 GUO Jingang;LEI Chengbin(Zibo City Central Hospital of Gaoqing Yuanqu,G aoqing 256300,China)
出处 《中国医学创新》 CAS 2018年第30期28-32,共5页 Medical Innovation of China
关键词 U0126 急性白血病 HL-60 增殖 凋亡 U0126 Acute leukemia HL-60 Proliferation Apoptosis
  • 相关文献

参考文献5

二级参考文献28

  • 1李印,周清华,孙芝琳,孙泽芳,王艳萍,覃扬,朱文,陈晓禾.靶向抑制ERK1/2信号传导通路对人高转移大细胞肺癌细胞株L9981恶性表型的影响[J].中国肺癌杂志,2005,8(6):504-509. 被引量:3
  • 2Roberts PJ, Der CJ. Targting the Raf-MEK-ERK mitogen-activated protein kinase for the treatment of cancer! J l. ()ncogene, 2007,26 (22) :3291 -3310.
  • 3Li Q, Wu J ,Zheng H ,et al. Discovery of 3-( 2-aminoethyl ) -5-( 3-phcn-yl-propylidene) -thiazolidine- 2,4-dione as a dual inhibitor of the Raf/ MEK/ERK and the PI3K/Akt signaling pathways[J]. Bioorganic & Medicinal Chemistry" Letters ,2010,20 ( 15 ) :4526 - 4530.
  • 4Olivier S,Robe P,Bours V. Can NF-kB be a target for novel and effi- cient anti-cancer agents ? [ J ]. Biochem Pharmacol, 2006,72 ( 9 ) : 1054 - 1068.
  • 5Mouawad R, Sebert M, Michels J, et al. Treatment for metastatic malig- nant melanoma:Old drugs and new strategies [ J ]. Critical Reviews in Oncology/Hematology,2010,74 ( 1 ) :27 - 39.
  • 6Ji Z, Flaherty KT, Tsao H, et al. Targeting the RAS pathway in melano- ma [ J ]. Trends in Molecular Medicine,2012,18 ( 1 ) :27 - 33.
  • 7Ji Z,Flaherty KT,Tsao H. Molecular therapeutic approaches to melano- ma [ J ]. Molecular Aspects of Medicine,2010,31 (2) : 194 - 204.
  • 8Fukazawa H, Noguchi K, Murakami Y, et al. Mitogen-activated protein/ extrace|lular signal- regulated kinase kinase (MEK) inhibitors restore anoikis sensilivity in human breast cancer cell lines with a constitutive- ly activated extracellular-regulated kinase (ERK) pathway [ J ]. Mol Cancer Ther,2002, l (5) : 303 - 309.
  • 9Lind CR, Gray CW, Person AG, et al. The mitogen-activated/extracel- lularsigrtal-regulated kinasse kinaset/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells [ J ]. Neuroscience ,2006,141 (4) : 1925 - 1933.
  • 10Tsubaki M, Satan T, hob T,et al. Reduction of metastasis, cell inva- sion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-in- duced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway [J]. Toxicol Appl Phamlacol,2012,259 (3) :402 -410.

共引文献33

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部